{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T08:06:35Z","timestamp":1750925195287,"version":"3.37.3"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":350,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017035","name":"ISREC Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.ctarc.2024.100858","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:45:18Z","timestamp":1734453918000},"page":"100858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis"],"prefix":"10.1016","volume":"42","author":[{"given":"Louis-Emmanuel","family":"Chriqui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Abdelnour-Berchtold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Zanfrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severine","family":"Devesa-Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Ellefsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Destaillats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasna","family":"Bouchaab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Bassani-Sternberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Cavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7918-0793","authenticated-orcid":false,"given":"Jean Y","family":"Perentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ctarc.2024.100858_bib0001","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1111\/1759-7714.14224","article-title":"Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world","volume":"12","author":"Pan","year":"2021","journal-title":"Thorac. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2024.100858_bib0002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural pH as a predictor of survival in patients with malignant pleural effusion","volume":"117","author":"Heffner","year":"2000","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.ctarc.2024.100858_bib0003","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/thorax-2023-220304","article-title":"British thoracic society guideline for pleural disease","volume":"78","author":"Roberts","year":"2023","journal-title":"Thorax."},{"key":"10.1016\/j.ctarc.2024.100858_bib0014","article-title":"Hyperthermic intrathoracic chemotherapy modulates the immune microenvironment of pleural mesothelioma and improves the impact of dual immune checkpoint inhibition","author":"Hao","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"9","key":"10.1016\/j.ctarc.2024.100858_bib0004","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jtho.2018.04.032","article-title":"A phase I trial of surgical resection and intraoperative hyperthermic cisplatin and gemcitabine for pleural mesothelioma","volume":"13","author":"Burt","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.ctarc.2024.100858_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595207","article-title":"Hyperthermia targeting the tumor microenvironment facilitates immune checkpoint inhibitors","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.ctarc.2024.100858_bib0008","article-title":"Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.ctarc.2024.100858_bib0009","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","article-title":"How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures","volume":"22","author":"Giger-Pabst","year":"2018","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.ctarc.2024.100858_bib0010","first-page":"183","article-title":"Pressurized IntraThoracic aerosol chemotherapy (PITAC)","author":"Jonscher","year":"2014","journal-title":"Cancer under Pressure"},{"key":"10.1016\/j.ctarc.2024.100858_bib0011","doi-asserted-by":"crossref","unstructured":"Willaert W, Sessink P, Ceelen W, Occupational safety in pressurized aerosol chemotherapy protocols PIPAC Pleura Peritoneum 2017 Sep 1;2(3):121\u2013128.","DOI":"10.1515\/pp-2017-0018"},{"issue":"4","key":"10.1016\/j.ctarc.2024.100858_bib0012","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jpainsymman.2015.04.015","article-title":"Practical dyspnea assessment: relationship between 0-10 numerical rating scale and four level categorical verbal descriptor of dyspnea intensity","volume":"50","author":"Wysham","year":"2015","journal-title":"J. Pain Sympt. Manage"},{"issue":"6","key":"10.1016\/j.ctarc.2024.100858_bib0013","first-page":"518","article-title":"ntrapleural use of tissue plasminogen activator and DNase in pleural infection NEJM","volume":"365","author":"Rahman","year":"2011","journal-title":"I"},{"issue":"3","key":"10.1016\/j.ctarc.2024.100858_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.23736\/S0026-4733.18.07649-6","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: morbidity and postoperative outcomes","volume":"74","author":"Robella","year":"2019","journal-title":"Minerva Chir."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100858_bib0016","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2020-0129","article-title":"Technique of pressurized intrathoracic aerosol chemotherapy (PITAC) for malignant pleural effusion","volume":"5","author":"Drevet","year":"2020","journal-title":"Pleura Peritoneum."},{"issue":"17","key":"10.1016\/j.ctarc.2024.100858_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173801","article-title":"Hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: the forefront of surgery-based multimodality treatment","volume":"10","author":"Aprile","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2024.100858_bib0018","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2019.12.007","article-title":"Regulatory T cells restrain interleukin-2- and blimp-1-dependent acquisition of cytotoxic function by CD4(+) T cells","volume":"52","author":"Sledzinska","year":"2020","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.ctarc.2024.100858_bib0019","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jtcvs.2007.10.026","article-title":"Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma","volume":"135","author":"Anraku","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"5","key":"10.1016\/j.ctarc.2024.100858_bib0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/1043-4666(91)90042-C","article-title":"Temperature is a powerful promoter of interleukin 2 transcription","volume":"3","author":"Gern","year":"1991","journal-title":"Cytokine"},{"key":"10.1016\/j.ctarc.2024.100858_bib0021","unstructured":"Declaration of Helsinki. 2013."},{"year":"1996","series-title":"E6(R2) guideline for good clinical practice","key":"10.1016\/j.ctarc.2024.100858_bib0022"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294224000704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T12:35:59Z","timestamp":1739018159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294224000704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":20,"alternative-id":["S2468294224000704"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100858","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2024.100858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100858"}}